海特生物
(300683)
| 流通市值：32.47亿 | | | 总市值：34.78亿 |
| 流通股本：1.22亿 | | | 总股本：1.31亿 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 197,834,917.79 | 262,378,332.58 | 648,326,909.6 | 169,536,509.9 |
| 交易性金融资产 | 196,937,507.38 | 161,142,419.03 | 170,629,291.07 | 526,217,228.18 |
| 应收票据及应收账款 | 70,040,799.35 | 68,913,292.33 | 65,350,045.21 | 70,273,704.53 |
| 其中：应收票据 | 4,465,260.94 | 1,891,531.76 | 3,188,348.62 | 6,111,605.38 |
| 应收账款 | 65,575,538.41 | 67,021,760.57 | 62,161,696.59 | 64,162,099.15 |
| 应收款项融资 | 2,331,684.87 | 6,192,037.82 | 13,509,461.97 | 10,849,112.41 |
| 预付款项 | 3,918,860.93 | 10,808,399.8 | 5,361,523.83 | 7,359,727.94 |
| 其他应收款合计 | 3,612,845.84 | 3,815,590.15 | 4,064,551.08 | 3,949,391.75 |
| 存货 | 84,568,388.95 | 79,159,770.2 | 82,937,125.91 | 85,388,216.99 |
| 合同资产 | 219,271,639.21 | 264,819,466.83 | 219,715,538.45 | 228,232,055.76 |
| 一年内到期的非流动资产 | 65,000,000 | - | - | - |
| 其他流动资产 | 387,470,227.73 | 380,871,646.38 | 19,970,519.49 | 26,928,887.61 |
| 流动资产合计 | 1,230,986,872.05 | 1,238,100,955.12 | 1,229,864,966.61 | 1,128,734,835.07 |
| 非流动资产: | | | | |
| 长期股权投资 | 35,993,380.79 | 37,894,532.27 | 38,696,102.91 | 30,944,174.29 |
| 其他权益工具投资 | 4,150,000 | 4,150,000 | 4,150,000 | 4,150,000 |
| 固定资产 | 621,616,841.11 | 632,512,755.93 | 646,059,487.02 | 664,745,575.75 |
| 在建工程 | 11,827,148.35 | 11,418,519.04 | 7,356,140.99 | 7,188,566.73 |
| 固定资产清理 | - | - | - | 4,071.08 |
| 使用权资产 | 4,170,420.74 | 4,421,260.19 | 4,726,263.17 | 5,988,992.38 |
| 无形资产 | 216,694,600.54 | 223,176,149.35 | 229,091,647 | 235,290,701.17 |
| 开发支出 | 23,061,504.94 | 22,777,578.26 | 24,937,452.09 | 24,937,452.09 |
| 商誉 | 178,591,202.15 | 178,591,202.15 | 178,591,202.15 | 178,591,202.15 |
| 长期待摊费用 | 8,936,556.69 | 9,294,575.6 | 9,573,034.51 | 5,941,441.68 |
| 递延所得税资产 | 127,041,942.1 | 123,532,177.32 | 120,522,203.84 | 127,751,429.14 |
| 其他非流动资产 | 8,197,450.74 | 58,864,810 | 82,974,129.86 | 222,712,757.79 |
| 非流动资产合计 | 1,240,281,048.15 | 1,306,633,560.11 | 1,346,677,663.54 | 1,508,246,364.25 |
| 资产总计 | 2,471,267,920.2 | 2,544,734,515.23 | 2,576,542,630.15 | 2,636,981,199.32 |
| 流动负债: | | | | |
| 短期借款 | 7,058,264.73 | 7,058,264.73 | 7,058,264.73 | 7,135,286.26 |
| 交易性金融负债 | - | - | 23,180,000 | - |
| 应付票据及应付账款 | 34,673,078.95 | 57,545,944.81 | 33,134,039.21 | 43,518,735.02 |
| 应付账款 | 34,673,078.95 | 57,545,944.81 | 33,134,039.21 | 43,518,735.02 |
| 合同负债 | 47,024,241.7 | 47,320,378.38 | 53,773,169.56 | 53,076,878.67 |
| 应付职工薪酬 | 13,039,269.18 | 12,748,541.48 | 18,763,811.31 | 14,585,117.52 |
| 应交税费 | 5,178,693.43 | 6,322,722.92 | 4,565,485.65 | 6,361,150.64 |
| 其他应付款合计 | 126,838,319.72 | 118,472,808.54 | 105,715,017.14 | 91,466,721.42 |
| 一年内到期的非流动负债 | 44,237,600.38 | 44,968,639.42 | 60,008,727.9 | 27,184,706.54 |
| 其他流动负债 | 3,992,861.42 | 2,823,029.42 | 2,646,657.24 | 2,162,930 |
| 流动负债合计 | 282,042,329.51 | 297,260,329.7 | 308,845,172.74 | 245,491,526.07 |
| 非流动负债: | | | | |
| 租赁负债 | 3,392,183.78 | 3,647,703.01 | 3,900,193.79 | 4,055,822.92 |
| 长期应付款 | - | - | - | 45,915,572.75 |
| 递延收益 | 85,407,289.65 | 87,160,000.97 | 83,042,806.6 | 84,258,006.29 |
| 递延所得税负债 | 10,462,720.22 | 10,895,529.59 | 11,354,968.54 | 13,364,262.61 |
| 非流动负债合计 | 99,262,193.65 | 101,703,233.57 | 98,297,968.93 | 147,593,664.57 |
| 负债合计 | 381,304,523.16 | 398,963,563.27 | 407,143,141.67 | 393,085,190.64 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 130,894,391 | 130,894,391 | 130,894,391 | 130,894,391 |
| 资本公积 | 1,836,919,613.31 | 1,836,919,613.31 | 1,836,919,613.31 | 1,836,919,613.31 |
| 专项储备 | 452,258.8 | 304,624 | - | - |
| 盈余公积 | 53,879,686.43 | 53,879,686.43 | 53,879,686.43 | 53,672,883.33 |
| 未分配利润 | 60,123,844.65 | 115,784,663.82 | 138,830,932.23 | 212,159,559.02 |
| 归属于母公司股东权益合计 | 2,082,269,794.19 | 2,137,782,978.56 | 2,160,524,622.97 | 2,233,646,446.66 |
| 少数股东权益 | 7,693,602.85 | 7,987,973.4 | 8,874,865.51 | 10,249,562.02 |
| 股东权益合计 | 2,089,963,397.04 | 2,145,770,951.96 | 2,169,399,488.48 | 2,243,896,008.68 |
| 负债和股东权益合计 | 2,471,267,920.2 | 2,544,734,515.23 | 2,576,542,630.15 | 2,636,981,199.32 |
| 公告日期 | 2026-08-24 | 2026-04-24 | 2026-04-24 | 2025-10-23 |
| 审计意见(境内) | | | 标准无保留意见 | |